oIssues related to the reauthorization of the FDA drug and device user fee programs oIssues related to data privacy and security oGovernment response to COVID-19, including liability reforms and supply chain issues oDiagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2021 (S.2209, H.R. 4128) oCancer Patient Equity Act of 2021 (H.R. 5377) oBiomarker Testing Coverage Policies Other proposed policies that could affect the coverage, reimbursement, regulation of diagnostic tests or the operations of clinical laboratories. oBiomarker Testing Coverage Policies oCancer Patient Equity Act of 2021 (H.R. 5377) Other proposed policies that could affect the coverage, reimbursement, regulation of diagnostic tests or the operations of clinical laboratories.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FOUNDATION MEDICINE, INC.
150 Second Street, Cambridge, MA, 02141, US
JENNIFER ROMANS JENNIFER ROMANS